No Data
Tianjin Tianyao Pharmaceuticals (600488.SH): Over 60% of the company's steroid active pharmaceutical ingredients are exported.
On November 12, tianjin tianyao pharmaceuticals (600488.SH) stated at the performance briefing that currently, the company's active pharmaceutical ingredient products sales have covered more than 70 countries and regions globally including North and South America, Asia, and Europe. The process technology and product quality of some varieties have reached the international advanced level, making it a research, production, and export base for Asian steroid hormone drugs. Over 60% of the company's steroid hormone active pharmaceutical ingredients are exported.
Tianyao Pharmaceuticals Unit Gets China Nod for Additional Specifications for Anti-Wheezing Drug
Report for the third quarter of 2024 of Tianjin Pharmaceutical Co., Ltd.
Tianjin Tianyao Pharmaceuticals (600488.SH): The net income in the first three quarters was 0.187 billion yuan, a year-on-year increase of 23.03%.
On October 29, Ge Longhui reported that Tianjin Tianyao Pharmaceuticals (600488.SH) announced its third-quarter report, with revenue of 2.572 billion yuan in the first three quarters, a 9.36% year-on-year decrease. Net income was 0.187 billion yuan, a 23.03% year-on-year increase, non-GAAP net profit was 0.184 billion yuan, a 27.30% year-on-year increase, and basic earnings per share was 0.171 yuan.
tianjin tianyao pharmaceuticals (600488.SH) released its performance for the first three quarters, with a net income of 0.187 billion yuan, a year-on-year increase of 23.03%.
tianjin tianyao pharmaceuticals (600488.SH) released the third quarter report for 2024, and during the reporting period the company achieved revenue...
Should You Be Adding Tianjin Tianyao Pharmaceuticals (SHSE:600488) To Your Watchlist Today?
Earnings Not Telling The Story For Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE:600488)No Data
No Data
